These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34445741)

  • 1. SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites.
    Lechuga GC; Souza-Silva F; Sacramento CQ; Trugilho MRO; Valente RH; Napoleão-Pêgo P; Dias SSG; Fintelman-Rodrigues N; Temerozo JR; Carels N; Alves CR; Pereira MCS; Provance DW; Souza TML; De-Simone SG
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
    Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study.
    Khan MT; Zeb MT; Ahsan H; Ahmed A; Ali A; Akhtar K; Malik SI; Cui Z; Ali S; Khan AS; Ahmad M; Wei DQ; Irfan M
    Arch Microbiol; 2021 Jan; 203(1):59-66. PubMed ID: 32749662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Binding Site of Remdesivir and Its Metabolites with NSP12-NSP7-NSP8, and NSP3 of SARS CoV-2 Virus and Alternative Potential Drugs for COVID-19 Treatment.
    Jung LS; Gund TM; Narayan M
    Protein J; 2020 Dec; 39(6):619-630. PubMed ID: 33185784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
    Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
    Elife; 2021 Aug; 10():. PubMed ID: 34435953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of SARS-CoV-2 Structural Proteins to Hemoglobin and Myoglobin Studied by SPR and DR LPG.
    Dyankov G; Genova-Kalou P; Eftimov T; Ghaffari SS; Mankov V; Kisov H; Veselinov P; Hikova E; Malinowski N
    Sensors (Basel); 2023 Mar; 23(6):. PubMed ID: 36992057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Insights into Hemopexin-Binding to Hemin and Hemoglobin.
    Lechuga GC; Napoleão-Pêgo P; Morel CM; Provance DW; De-Simone SG
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
    Yadav R; Chaudhary JK; Jain N; Chaudhary PK; Khanra S; Dhamija P; Sharma A; Kumar A; Handu S
    Cells; 2021 Apr; 10(4):. PubMed ID: 33917481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal analysis of SARS-CoV-2 spike and RNA-dependent RNA polymerase protein sequences reveals the emergence and geographic distribution of diverse mutations.
    Showers WM; Leach SM; Kechris K; Strong M
    Infect Genet Evol; 2022 Jan; 97():105153. PubMed ID: 34801754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revealing the Structural Plasticity of SARS-CoV-2 nsp7 and nsp8 Using Structural Proteomics.
    Courouble VV; Dey SK; Yadav R; Timm J; Harrison JJEK; Ruiz FX; Arnold E; Griffin PR
    J Am Soc Mass Spectrom; 2021 Jul; 32(7):1618-1630. PubMed ID: 34121407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein.
    Park BK; Kim J; Park S; Kim D; Kim M; Baek K; Bae JY; Park MS; Kim WK; Lee Y; Kwon HJ
    Theranostics; 2021; 11(8):3853-3867. PubMed ID: 33664866
    [No Abstract]   [Full Text] [Related]  

  • 15. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligomeric assembly of the C-terminal and transmembrane region of SARS-CoV-2 nsp3.
    Babot M; Boulard Y; Agouda S; Pieri L; Fieulaine S; Bressanelli S; Gervais V
    J Virol; 2024 Apr; 98(4):e0157523. PubMed ID: 38483167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Host Interactomes of the SARS-CoV-2 Nonstructural Protein 3 and Human Coronavirus Homologs.
    Almasy KM; Davies JP; Plate L
    Mol Cell Proteomics; 2021; 20():100120. PubMed ID: 34186245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
    David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
    Molecules; 2021 May; 26(11):. PubMed ID: 34072087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural basis of accelerated host cell entry by SARS-CoV-2†.
    Seyran M; Takayama K; Uversky VN; Lundstrom K; Palù G; Sherchan SP; Attrish D; Rezaei N; Aljabali AAA; Ghosh S; Pizzol D; Chauhan G; Adadi P; Mohamed Abd El-Aziz T; Soares AG; Kandimalla R; Tambuwala M; Hassan SS; Azad GK; Pal Choudhury P; Baetas-da-Cruz W; Serrano-Aroca Á; Brufsky AM; Uhal BD
    FEBS J; 2021 Sep; 288(17):5010-5020. PubMed ID: 33264497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.
    Dakal TC
    Immunobiology; 2021 Jan; 226(1):152021. PubMed ID: 33232865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.